A Cross Over Pilot Study of Abobotulinum Toxin A (Dysport) as a Treatment for Task-dependent Upper Limb Tremor

PHASE4RecruitingINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

December 4, 2018

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
Tremor, Limb
Interventions
DRUG

Abobotulinum toxin A

Dosing will be determined at each study visit based upon muscles involved

OTHER

Placebo

Dosing will be determined at each study visit based upon muscles involved

Trial Locations (1)

10029

RECRUITING

Icahn School of Medicine at Mount Sinai, New York

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Ipsen

INDUSTRY

lead

David M. Simpson

OTHER

NCT03136341 - A Cross Over Pilot Study of Abobotulinum Toxin A (Dysport) as a Treatment for Task-dependent Upper Limb Tremor | Biotech Hunter | Biotech Hunter